The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Alcon holds more than 70% of Wavelights shares and its takeover of Wavelight has been approved by the German authorities. WHile wavelight produces some interesting intraocular lenses, it is clear that Alcons interest in Wavelight lies in its realiable and fast excimer laser system that can be used for...
New research indicating the presence of amyloid-beta protein in dying retinal cells suggests a new direction in glaucoma research. Amyloid-beta is a protein found in Alzheimer's plaques. Using a rat model of glaucoma, the researchers found that the dying retinal cells
showed accumulation of amyloid-beta....
LX211, calcineurin inhibitor and antiinflammatory drug, was granted Fast Track designation by the FDA. This move could expedite its approval for the management of non-infectious posterior, intermediate and panuveitis. In a field where there are few approved treatment modalities, this could be very big...
This brief article describes the comments of the Advanced Medical Optics (AMO) President and CEO which deflect the blame of the recent contact lens infection on the consumer on poor contact lens hygiene. Although the comments of the AMO brass may be indeed true, there is not a single entity to...
Boxer Sugar Ray Leonard had a complex retinal detachment, Orlando Brown of football was nearly blinded by a referee's thrown flag. Soft contact lens wear is barely compatible with sweaty, dusty contact sports. Some great basketball players wore (& wear) goggles. Asking boxers to wear...
It seems most likely that the reason that the major ophthalmic houses did not want the Crystalens-Eyeonics company is that the technology has substantial problems. Unlike the multifocal lenses, in order to give the best possible distance vision, near vision is not...
Biodem (ASX:BDM) is conducting a a Phase I/II trail involving a 10 day course of subcutaneous injection of a peptide in the treatment of diabetic macular edema. The results of this trial which is being conducted abroad in Russia will be available in November 2007. Although promising...
LX211, calcineurin inhibitor and antiinflammatory drug, was granted Fast Track designation by the FDA. This move could expedite its approval for the management of non-infectious posterior, intermediate and panuveitis. In a field where there are few approved treatment modalities, this could...
Rather than getting gobbled up by one of the big three players in Ophthalmology (B & L, Alcon and AMO), eyeonics is looking to go it alone into the public arena. The crystalens remains the only approved accommodative intraocular lens, but faces strong competition from the multifocals. ...
Tears of the retinal pigment epithelium (RPE) may develop during the course of anti-VEGF therapy for age-related macular degeneration (AMD) related pigment epithelial detachment (PED), according to a study published in the June issue of Retina. A total of 33 cases of RPE tear after treatment with...